Metastatic Renal Cell Carcinoma Change Vascularity
Joint Authors
Sato, Yujiro
Matayoshi, Yukihide
Azuma, Takeshi
Nagase, Yasushi
Sato, Yohsuke
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-08-30
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Several molecular targeted agents have been approved for clinical use for metastatic renal cell carcinoma (mRCC).
A case of a 32-year-old woman with mRCC is presented.
These tumors could change vascularity by administration of molecular agents.
We could select a drug timely based on findings of computed tomography.
To our knowledge, this is the first report that tumor’s character change induced by molecular targeted agents can be detected and the efficacy of molecular targeted agents can be predicted.
American Psychological Association (APA)
Azuma, Takeshi& Matayoshi, Yukihide& Sato, Yohsuke& Sato, Yujiro& Nagase, Yasushi. 2012. Metastatic Renal Cell Carcinoma Change Vascularity. Case Reports in Urology،Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-488636
Modern Language Association (MLA)
Azuma, Takeshi…[et al.]. Metastatic Renal Cell Carcinoma Change Vascularity. Case Reports in Urology No. 2012 (2012), pp.1-3.
https://search.emarefa.net/detail/BIM-488636
American Medical Association (AMA)
Azuma, Takeshi& Matayoshi, Yukihide& Sato, Yohsuke& Sato, Yujiro& Nagase, Yasushi. Metastatic Renal Cell Carcinoma Change Vascularity. Case Reports in Urology. 2012. Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-488636
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-488636
